Skip Navigation



JAC Advance Access published online on December 1, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl462
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
59/1/159    most recent
dkl462v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sriskandan, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sriskandan, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Correspondence

Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation--author's response

Shiranee Sriskandan 1 *

1 Department of Infectious Diseases and Immunity, Hammersmith Hospital, Imperial College London, Du Cane Road, London W12 0NN, UK

* To whom correspondence should be addressed.
Shiranee Sriskandan, E-mail: s.sriskandan{at}imperial.ac.uk



This article has no Abstract. Keywords: bacterial infections; models; septic shock; Streptococcus pyogenes; immunology; immunomodulators.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.